FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicine, announced today that full enrollment has been ...
A research team has successfully developed a next-generation coil interface capable of efficiently and safely stimulating peripheral nerves. This breakthrough is significant in that it greatly ...
FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health ® Systems, Inc. (Nasdaq: TIVC), a health tech company developing and commercializing bioelectronic medicine, announced today that the first study subject ...
Dysphagia, a severe comorbidity of many neurological diseases, often lacks targeted therapies. This critical review assessed ...
Studies reported a 35% reduction in self-reported anxious thoughts following structured auricular vagus nerve stimulation, with improvements persisting beyond the stimulation period.” — Studies using ...
Current Primary Outcome Measures •Numeric Rating Scale at 60 days and 90 days post procedure (lead removal) [ Time Frame: at 60 days (plus or minus 5 days) and 90 days (plus or minus 10 days) ] ...
We compared Nuropod, gammaCore, Pulsetto, and Sensate across science, safety, stimulation method, usability, hidden costs, and long-term value.